Riskpilot← Back to searchSign inGet full accessMedtrac AB
ABIn liquidationOrg 5563350601Other software publishing · NACE 5829Est. 19880 employees
Revenue 2023
SEK 425K
EBITDA margin
80.2%
+3689% vs 2022
Equity ratio
46.8%
Financial strength
Net profit 2023
SEK -950K
-102% vs 2022
| Revenue | SEK 425K | — |
| EBITDA | SEK 341K | +3689% |
| Net profit | SEK -950K | -102% |
| Total assets | SEK 235K | -99% |
| Equity | SEK 110K | -100% |
| Employees | 0 | — |
Legal name
Medtrac AB
Org number
5563350601
Legal form
Aktiebolag
NACE code
5829 · Other software publishing
Founded
29 september 1988
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall producera och sälja dataprogram, tillhandahålla support för dessa program och bedriva utbildning i dataprogram inom sjukvårdssektorn samt tillhandahålla läkartjänster. Bolaget ska även tillhandahålla konsulttjänster och utbildningar som möjliggör effektiv dataprogramanvändning, såsom dokumentation och kvalitetsutveckling och därmed förenlig verksamhet.Bolaget ska även tillhandahålla läkartjänster.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 425 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −9 | −7 | −8 | −10 | 341 |
| Depreciation & amort. | −0 | −0 | −0 | — | −0 |
| EBIT | −9 | −7 | −8 | −10 | 341 |
| Net financials | 385 | — | 1 400 | 39 415 | −2 661 |
| Profit before tax | 376 | −7 | 1 392 | 39 406 | −825 |
| Tax | −0 | −0 | −0 | — | −125 |
| Net profit | 376 | −7 | 1 392 | 39 406 | −950 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 237 | 1 230 | 2 623 | 39 713 | 235 |
| Equity | 1 228 | 1 222 | 2 614 | 39 704 | 110 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 9 | 9 | 9 | 9 | 125 |
| Total debt | 9 | 9 | 9 | 9 | 125 |
EBITDA margin
80.2%
This company
15.8%
Market median
+408% vs market
20192023
Equity ratio
46.8%
This company
38.2%
Market median
+23% vs market
20192023
Return on equity
-863.6%
This company
18.4%
Market median
-4793% vs market
20192023
Net profit margin
-223.5%
This company
8.1%
Market median
-2859% vs market
20192023
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
20192023
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JF Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medtrac AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Ståhl | Liquidator | 0 companies |
| Ann Madeleine Sundin | Board of Directors | 0 companies |
| Martina Emilie Stenström | Deputy Board Member | 0 companies |
| Per Anders Larsson Stenström | Board of Directors | 0 companies |
| Maria Elisabeth Edward | Deputy Board Member | 0 companies |